Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01751698 · ClinicalTrials.gov registry record · NA
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
A NA study of Autism, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 192
- Enrollment target
- 4
- Study locations
NCT01751698: Completed NA study of Autism, sponsored by University of California, Los Angeles.
NCT01751698 is a NA study of Autism that has completed, run by University of California, Los Angeles. The registered enrollment target is 192 participants, roughly in line with the 182-participant average among 104 other Autism trials with a reported enrollment target. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01751698, a NA study of Autism, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
- 4
- Study locations
Study Summary
Adaptive Interventions for Minimally Verbal Children with ASD in the Community, seeks support to construct an adaptive intervention that utilizes two efficacious interventions (JASP-EMT and CORE- DTT) that have shown promise for optimizing the number of unique socially communicative and spontaneously spoken words in minimally verbal children with ASD. The study utilizes a novel sequential multiple assignment-randomized trial to evaluate and construct an optimal adaptive intervention. A total of 192 minimally verbal school aged children with an Autism Spectrum Disorder (aged 5 to 8 years of age) will participate across four sites, University of California Los Angeles, University of Rochester, Vanderbilt University and Weill Cornell Medical Center with methodological and statistical support from University of Michigan.
Primary Outcome
To determine which intervention for minimally verbal children (JASP-EMT vs. CORE-DTT) produces greater increases in socially communicative spontaneous utterances (SCU; primary outcome).
Conditions Studied
Interventions
- BEHAVIORAL JASP-EMT
- BEHAVIORAL DTT
Study Locations (4)
New York
- University of Rochester - Rochester
- Weill Cornell Medical College - White Plains
California
- University of California, Los Angeles - Los Angeles
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2013-01 |
| Est. Completion | 2017-12 |
| Phase | NA |
What the finished NCT01751698 record still lists
NCT01751698 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 182-participant average among 104 other Autism trials with a reported enrollment target.
The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 2 interventions - of which JASP-EMT is the first listed.
NCT01751698 reports a single indexed study location in New York, California, Tennessee.
Frequently Asked Questions
What is clinical trial NCT01751698 about?
NCT01751698 is a clinical study titled "Adaptive Interventions for Minimally Verbal Children With ASD in the Community". Adaptive Interventions for Minimally Verbal Children with ASD in the Community, seeks support to construct an adaptive intervention that utilizes two efficacious interventions (JASP-EMT and CORE- DTT) that have shown promise for optimizing the number of unique socially communicative and spontaneousl...
What is the current status of trial NCT01751698?
This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 2013-01. Estimated completion is 2017-12.
What conditions does trial NCT01751698 study?
This clinical trial studies the following conditions: Autism.
What interventions are being tested in trial NCT01751698?
The interventions under investigation include: JASP-EMT (BEHAVIORAL), DTT (BEHAVIORAL).
Who is sponsoring clinical trial NCT01751698?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01751698 being conducted?
This trial has 4 study locations across California, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01751698's enrollment target sits among peer trials
192 23rd of 104 higher than 82 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia